Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /357230

H.PIO Co., Ltd.

357230

• KRX: 357230 • Delayed

2,535KRW -0.2%

1.63 USD

As of 8 June 2026, H.PIO Co., Ltd. has a market cap of $68.26M USD, ranking #28298 globally and #1493 in South Korea. It ranks #2563 in the Healthcare sector, and #140 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

28298

Country Rank

1493

Sector Rank

2563

Industry Rank

140

Key Stats

Market Cap

$68.26MUSD

104.64B KRW

Enterprise Value

$70.51MUSD

110.0B KRW

Revenue (TTM)

$168.44MUSD

258.19B KRW

EBITDA (TTM)

$13.74MUSD

21.44B KRW

Net Income (TTM)

$5.49MUSD

8.42B KRW

EBITDA Margin

8.3%

Profit Margin

3.3%

PE Ratio

12.4

PS Ratio

0.4

PB Ratio

0.5

EV/EBITDA

5.1

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

Founded

2012

Website

denps.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	-2.3%	4.8%	-0.8%	-1.9%	4.8%	-3.2%	-30%	-72%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	357230 H.PIO Co Ltd ISIN: KR7357230002 Shares Out.: Shares Outstanding: 41.289M¹ Shares Float: 10.621M² TV: TradingView: KRX: 357230 SA: Stock Analysis: KRX: 357230 YF: Yahoo Finance: 357230.KS GF: Google Finance: KRX: 357230 BA: Barron's: 357230 MS: Morningstar: XKRX: 357230	2,535 KRW	TV: TradingView: KRX: 357230 SA: Stock Analysis: KRX: 357230 YF: Yahoo Finance: 357230.KS GF: Google Finance: KRX: 357230 BA: Barron's: 357230 MS: Morningstar: XKRX: 357230

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About H.PIO Co., Ltd.

H.PIO Co., Ltd., a health and lifestyle company, develops, manufactures, and sells health functional foods under the Denps brand worldwide. It offers lactic acid bacteria, vitamins, etc. The company was founded in 2012 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Myung In Pharmaceutical LTD. KRX: 317450	$539.11M 826.36B KRW 690%	8.4	South Korea
FutureChem Co.,Ltd KRX: 220100	$278.08M 426.25B KRW 307%	-	South Korea
KOLMAR BNH Co.,Ltd. KRX: 200130	$218.56M 335.01B KRW 220%	-	South Korea
Kwang Dong Pharmaceutical Co., Ltd. KRX: 009290	$203.29M 311.61B KRW 198%	16.3	South Korea
NOVAREX Co.,Ltd. KRX: 194700	$167.22M 256.31B KRW 145%	7.4	South Korea
Kyung Dong Pharmaceutical Co., Ltd. KRX: 011040	$98.78M 151.41B KRW 45%	17.8	South Korea

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 55K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 43K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 23K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 16K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 16K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 13K%	80.6	China

chevron_leftBack